Mercado Global de Medicamentos de Apoio ao Cancro – Tendências da Indústria e Previsão para 2028

Análise de mercado e insights: Mercado global de medicamentos de apoio ao cancro

Espera-se que o mercado de medicamentos de apoio ao cancro ganhe crescimento de mercado no período de previsão de 2021-2028. A Data Bridge Market Research analisa o mercado para crescer a um CAGR de 1,85% no período de previsão acima mencionado.

O tratamento de suporte, empregue na mitigação de vários tipos de cancro , melhora a sobrevivência e a qualidade de vida. Os cuidados de suporte oncológico visam aliviar os doentes das consequências negativas da terapia e dos tratamentos contra o cancro. Os efeitos secundários relacionados com o cancro e os efeitos secundários que os acompanham podem ser prevenidos e tratados com a ajuda de medicamentos de suporte para o tratamento do cancro. Anemia , náuseas, vómitos e falta de apetite são efeitos secundários do tratamento do cancro. Alguns dos medicamentos utilizados nos cuidados de suporte são a Rasburicase, a mesna, o ácido folínico, o dexrazoxano, o alopurinol e a amifostina. A Associação Multinacional de Cuidados de Apoio ao Cancro desenvolveu um critério de pontuação para identificar indivíduos com neutropenia febril de baixo risco.

O aumento da prevalência do cancro e o aumento do número de pessoas que sofrem dos efeitos secundários das terapias anticancerígenas são os principais fatores que impulsionam o crescimento do mercado. Além disso, o crescente consumo de medicamentos biossimilares, o desenvolvimento da infra-estrutura de saúde e as crescentes iniciativas de organizações governamentais e privadas para difundir e formular programas de sensibilização são os factores que irão expandir o mercado dos medicamentos de apoio ao cancro.

O aumento das atividades de investigação e desenvolvimento e dos mercados emergentes proporcionará oportunidades benéficas para o mercado de medicamentos de apoio ao cancro no período de previsão de 2021-2028.

No entanto, o elevado custo da medicação e os efeitos secundários associados aos medicamentos de suporte ao cancro são os fatores que dificultarão o crescimento do mercado e regras e regulamentos rigorosos desafiarão o mercado de medicamentos de suporte ao cancro no período de previsão acima mencionado.

This cancer supportive care drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cancer supportive care drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cancer Supportive Care Drugs Market Scope and Market Size

The cancer supportive care drugs market is segmented on the basis of cancer type, therapeutic class, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of cancer type, the cancer supportive care drugs market is segmented into lung cancer, prostate cancer, breast cancer, melanoma and others.
• On the basis of therapeutic class, the cancer supportive care drugs market is segmented into bisphosphonates, opioids, anti-emetics, nonsteroidal anti-inflammatory drug (NSAIDs), erythropoiesis stimulating agents (ESAs), granulocyte-colony stimulating factors (G-CSFs) and others.  Others have been further sub-segmented into antineoplastic antibiotics and neutropenia.
• On the basis of end-users, the cancer supportive care drugs market is segmented into clinic, hospital and others.
• The cancer supportive care drugs market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Cancer Supportive Care Drugs Market Country Level Analysis

The cancer supportive care drugs market is segmented on the basis of cancer type, therapeutic class, end-users and distribution channel.

The countries covered in the cancer supportive care drugs market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the cancer supportive care drugs market due to the presence of major key players, growing prevalence of cancer, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector, emergence of small players and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Cancer supportive care drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Cancer Supportive Care Drugs Market Share Analysis

Cancer supportive care drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global cancer supportive care drugs market research.

Os principais players abordados no relatório do mercado de medicamentos de apoio ao cancro são a Amgen Inc., a Novartis AG, a Merck Sharp & Dohme Corp., a Johnson & Johnson Private Limited, a F. Hoffmann-La Roche Ltd, a Helsinn Healthcare SA, a Heron Therapeutics, a Inc. , GlaxoSmithKline plc, Purdue Pharma LP, Baxter, Fagron, Teva Pharmaceuticals Industries Ltd., APR, Kyowa Kirin Co., Ltd. e Acacia Pharma Group Plc., entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-47995